[Saint Petersburg Institute of Bioregulation and Gerontology: achievements and prospects (towards the 20th anniversary)].
The article presents the results of the 20-years' long activity of the Saint Petersburg Institute of Bioregulation and Gerontology founded to fulfill the basic and applied tasks in the sphere of gerontology and to integrate with medical practice new methods for preventing premature aging and age-related pathology by means of pharmaceuticals based on peptide bioregulators. Among the Institute main achievements are the scientific developments in the field of peptide regulation of aging, creation of a new medical domain--bioregulation therapy, and foundation of the Russian school of biogerontology. As a result of investigations, a key role of peptides in the regulation of aging process has been established, and a method of bioregulators complex application has been developed to increase organism resistance to various unfavorable factors and enhancement of human vital resource. At present 6 drugs and over 60 peptide bioregulators are widely used for prevention and treatment of many diseases. 9 new peptide preparations revealing geroprotective properties are submitted to the Russian Health Ministry to be registered as drugs.